FindTrial
Sign In

The function of gamma delta T cells in patients with severe community acquired pneumonia

The function of gamma delta T cells in patients with severe community acquired pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018704
Enrollment
Unknown
Registered
2018-10-04
Start date
2018-10-15
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Interventions

Patients with severe community acquired pneumonia:No

Sponsors

Beijing Luhe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients with severe community acquired pneumonia who signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Complicated chronic renal insufficiency; 2. Immunosuppressive therapy; 3. History of malignant tumor.

Design outcomes

Primary

MeasureTime frame
The proportions of Delta 1+ T and V Delta 2+ T cells in peripheral blood and bronchoalveolar lavage fluid;—

Countries

China

Contacts

Public ContactJinxiang Wang

Beijing Luhe Hospital, Capital Medical University

wangjx0090@sina.com+86 13911469017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026